Substrate-specificities of acid and alkaline ceramidases in fibroblasts from patients with Farber disease and controls
- 1 August 1982
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 205 (2), 419-425
- https://doi.org/10.1042/bj2050419
Abstract
The specific activity of acid ceramidase was measured at pH 4.5 in normal fibroblasts and in fibroblasts from patients with Farber disease and obligate heterozygotes. Greater activity was found when the synthetically made ceramide substrates contained shorter-chain fatty acids or higher content of double bonds. Acid ceramidase activities towards N-lauroyl- (C12:0), N-myristoyl-(C14:0) and N-palmitoyl- (C16:0) sphingosine (C18:1) were respectively about 38, 26 and 6 times higher than the activity towards the N-stearoyl (C18:0) substrate. The activity towards N-linolenoylsphingosine (C18:3/C18:1), N-linoleoylsphingosine (C18:2/C18:1) and N-oleoylsphingosine (C18:1/C18:1) were respectively about 5, 4 and 3 times higher than the activity towards N-stearoylsphingosine (C18:0/C18:1). The activity towards N-stearoyldihydrosphingosine (C18:0/C18:0) was about 40% of that towards N-stearoylsphingosine. Fibroblast alkaline ceramidase possessed significant activity only towards ceramides of unsaturated fatty acids, with a pH optimum of about 9.0. Deficiency of acid ceramidase activity in fibroblasts from patients with Farber disease and intermediate activities in obligate heterozygotes were demonstrated with all ceramides examined except for N-hexanoylsphingosine (C6:0/C18:1), whereas alkaline ceramidase activity was unaffected. Comparative kinetic studies of acid ceramidase activity with N-lauroylsphingosine and N-oleoylsphingosine demonstrated about 5 (2-12)-fold and 7 (4-17)-fold higher Km values in fibroblasts from patients with Farber disease as compared with normal controls. N-Lauroylsphingosine, towards which acid ceramidase activity in control fibroblasts was about 10 times higher than that towards N-oleoylsphingosine, may serve as a better substrate for enzymic diagnosis of Farber disease as well as for further characterization of the catalytically defective acid ceramidase.This publication has 20 references indexed in Scilit:
- Ceramidase and ceramide synthesis in human kidney and cerebellumBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1975
- Above-normal urinary excretion of urinary ceramides in Farber's disease, and characterization of their components by high-performance liquid chromatography.1975
- Fatty acid composition of free ceramides of kidney and cerebellum from a patient with Farber's diseaseLipids, 1973
- Ceramidase Deficiency in Farber's Disease (Lipogranulomatosis)Science, 1972
- Biosynthesis and metabolic degradation of sphingolipids not containing sialic acidJournal of Lipid Research, 1972
- Ceramides in a Patient with Lipogranulomatosis (Farber's Disease) with Chronic CourseScandinavian Journal of Clinical and Laboratory Investigation, 1971
- Farber's lipogranulomatosisThe American Journal of Medicine, 1969
- Enzymic hydrolysis of sphingolipids. VIII. Purification and properties of rat brain ceramidaseBiochemistry, 1969
- The presence of sphingomyelin- and ceramide-cleaving enzymes in the small intestinal tractBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1969
- ENZYMATIC HYDROLYSIS OF SPHINGOLIPIDS .I. HYDROLYSIS AND SYNTHESIS OF CERAMIDES BY AN ENZYME FROM RAT BRAIN1966